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Abstract 
Background 
Leukaemia is a deadly clonal blood cancer originated from a single mutant progenitor blood 
cell, with wide prognosis and multifactorial aetiology. Mutations are needed to induce 
uncontrolled cell proliferation and avoid apoptosis. The tumour-suppressor gene p53 has been 
linked to inhibition of abnormal cell growth; while the chaperone molecule Heat Shock 
Protein-90 (HSP90) to cell proliferation. This project aimed to investigate the responses 
regarding cell viability and apoptosis of human Leukemic T-lymphoblasts cells (Jurkat E6.1) 
when exposed in vitro to new potential drugs. 
Method 
Jurkat E6.1 cells were incubated with different synthesized compounds (C1 to C4, C6 to C8, 
at concentrations of 50µM, 500µM and 1000µM) for 24 and 48 hours. Phosphate buffered 
saline was the negative control and hydroxyurea 500µM the positive. Cell viability and 
proliferation were determined using Trypan Blue exclusion assay and confirmed using FITC 
Annexin-V assay through flow cytometry. Gene expression of p53 and HSP90 was assessed 
by real time reverse transcriptase polymerase chain reaction.  
Results 
C2 at 500µM and C6 at 1000µM produced a significant reduction of cell viability (20% and 
58% at 24 hours; 35% and 64% at 48 hours respectively; p<0.05). There is a significant 
increase of cells undergoing early and late apoptosis post-treatment with C2 and C6 (p-
value<0.001). HSP90 gene was downregulated (24 hours) and p53 upregulated after 
treatment with C6. C2 induced downregulation of p53 and upregulation of HSP90.  
Conclusion 
C2 and C6 induced apoptosis in Jurkat E6.1 cells in vitro, also, C6 modified the gene 
expression of p53 and HSP90, thus suppressing cell proliferation and displaying promising 
anti-cancer activity. However, further investigation is required to verify results, assess 
cytotoxicity and evaluated other gene targets.  
 
